AstraZeneca says U.S. to buy additional 500,000 Evusheld doses

AstraZeneca> said on Wednesday the U.S. government has agreed to purchase an additional 500,000 doses of its antibody cocktail Evusheld used to treat COVID-19.

The company said the delivery of the doses was expected in the first quarter of 2022 and additional details about the deal would be announced in the coming weeks.